TTPH Short Information, Tetraphase Pharmaceuticals Inc.

Twenty Trading Day Totals
Total Shorted Volume	652,779
Total Actual Volume	3,087,814

Averages
Average Short Volume	32,639
Average Short Percentage	51.47%

Is there a TTPH Short Squeeze or Breakout about to happen?

See the TTPH Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2020-07-28	2.24	2.2	2.27	2.18	279,969	31,358	61.2425
2020-07-27	2.38	2.28	2.44	2.1703	501,384	49,914	20.8122
2020-07-24	2.28	2.38	2.4	2.27	373,882	94,586	40.6818
2020-07-23	2.38	2.28	2.4217	2.23	273,150	102,208	70.5535
2020-07-22	2.45	2.4	2.48	2.37	95,969	22,198	60.4142
2020-07-21	2.5	2.47	2.55	2.42	119,349	21,418	63.9000
2020-07-20	2.5	2.5199	2.5228	2.45	25,636	20,850	49.6937
2020-07-17	2.51	2.55	2.56	2.5	64,509	20,864	80.0891
2020-07-16	2.43	2.51	2.54	2.41	58,530	7,847	47.9939
2020-07-15	2.4	2.46	2.49	2.38	62,169	13,561	56.9670
2020-07-14	2.36	2.39	2.45	2.36	98,530	7,964	17.6097
2020-07-13	2.47	2.405	2.47	2.3474	107,996	33,618	61.4330
2020-07-10	2.46	2.43	2.48	2.4201	54,709	10,656	50.6271
2020-07-09	2.52	2.48	2.59	2.42	123,205	30,607	57.9821
2020-07-08	2.6	2.53	2.6	2.52	40,391	6,104	34.4372
2020-07-07	2.41	2.58	2.66	2.4	254,419	48,143	58.5098
2020-07-06	2.46	2.44	2.498	2.4101	129,699	33,918	66.3887
2020-07-02	2.54	2.46	2.56	2.4	227,851	65,743	61.0257
2020-07-01	2.51	2.56	2.56	2.495	70,290	7,192	24.7020
2020-06-30	2.53	2.52	2.58	2.5	126,177	24,030	44.3546

Stock Information

Tetraphase Pharmaceuticals Inc. Company Name:

TTPH Stock Symbol:

NASDAQ Market:

TTPH Short Information, Tetraphase Pharmaceuticals Inc.

Get TTPH Alerts

News, Short Squeeze, Breakout and More Instantly...

TTPH - La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.

SAN DIEGO, California and WATERTOWN, Massachusetts, July 28, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening disease...
TTPH - La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.

La Jolla agreement provides for $43.0 million in upfront cash plus potential future cash payments of up to $16.0 million pursuant to contingent value rights Combined company will offer two innovative therapies to treat patients suffering from life-threatening diseases SAN DIEGO, Ca...
TTPH - Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA TM (eravacycline for injection) to treat serious and life-threatening infections, today announced that on June 19, 2020, its Board of Directors received an uns...